Tonghua Dongbao Pharmaceutical Co., Ltd. (SHA:600867)

China flag China · Delayed Price · Currency is CNY
9.98
-0.01 (-0.10%)
Apr 8, 2026, 3:00 PM CST
Market Cap19.40B +33.2%
Revenue (ttm)2.74B +12.7%
Net Income1.23B +259.2%
EPS0.63 +292.9%
Shares Out1.94B
PE Ratio15.92
Forward PE38.38
Dividend0.25 (2.50%)
Ex-Dividend DateJun 25, 2025
Volume98,677,248
Average Volume54,526,536
Open10.12
Previous Close9.99
Day's Range9.82 - 10.16
52-Week Range7.04 - 10.38
Beta0.28
RSI65.96
Earnings DateApr 20, 2026

About SHA:600867

Tonghua Dongbao Pharmaceutical Co., Ltd. researches, develops, produces, and markets pharmaceuticals in China. It offers human insulin injections; insulin glargine injections; insulin aspart injections; liraglutide injections; and proprietary Chinese medicine. The company also provides insulin pen and pen needles; and chronic disease management platform, a diabetes management platform for drug treatment, blood glucose monitoring, and patient education. In addition, it offers chemical drugs, such as repaglinide, sitagliptin phosphate, and metfor... [Read more]

Sector Healthcare
Founded 1985
Employees 3,410
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600867
Full Company Profile

Financial Performance

Financial Statements